Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-08

Clinical Trial Update: Dexmedetomedine and Ketamine in Erector Spinae Block for Postoperative Analgesia Following Mastectomy. [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating dexmedetomidine and ketamine in erector spinae block for postoperative analgesia after mastectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Ketamine (ketamine)

Snippet

Sponsor: National Cancer Institute, Egypt | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: COMPLETED